John Hey work email
- Valid
- Valid
- Valid
John Hey personal email
- Valid
John Hey phone numbers
Specialties:Drug Development from Discovery through Phase 3 NeuropharmacologyPathobiology of neurodegenerationCardiovascular pharmacologyAutonomic pharmacologyPharmacokineticsADMEPulmonary pharmacologyAllergy and InflammationSafety pharmacologyOcular pharmacologyIntegrative pharmacologyPreclinical safetyPreclinical oncologyLead optimization Early clinical developmentDrug discovery and developmentToxicologyCMCTranslational MedicinePhamacogenomics
-
CsoAlzheon Aug 2013 - PresentFramingham, Ma, UsAlzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodrug that builds on the established safety and efficacy profile of the active compound in clinical trials of more than 2,000 patients. Our mission is to apply our discovery platform and development experience to unlock new classes of therapeutics that make a difference in patients’ lives by directly addressing the underlying pathology of devastating neurodegenerative disorders. www.alzheon.com -
Member Board Of TrusteesThomas More College Of Liberal Arts Jul 2021 - PresentNh, Us -
Executive Board MemberInternational Neurodegenerative Disorders Research Center Dec 2021 - Sep 2024
-
Drug Discovery And Development ConsultantIndependent Pharmaceutical Drug Development Consultant 2011 - Jun 2015
-
Lead For Dmpk And SafetyNimbus Discovery Sep 2012 - Jun 2014Cambridge, Ma, Us -
Senior Vice President Preclinical And Early DevelopmentNormoxys Inc. Jun 2010 - Dec 2012Us -
Senior Vice President, Discovery And Preclinical DevelopmentComentis, Inc Dec 2008 - Jul 2010South San Francisco, Ca, Us -
Vice President Of Discovery And Preclinical DevelopmentComentis, Inc Sep 2006 - Nov 2008South San Francisco, Ca, Us
-
Senior Director NeurobiologySchering Plough 1988 - 2006Rahway, New Jersey, Us
John Hey Skills
John Hey Education Details
-
University Of Oklahoma Health Sciences CenterPharmacology -
Kansas State UniversityPre-Medicine
Frequently Asked Questions about John Hey
What company does John Hey work for?
John Hey works for Alzheon
What is John Hey's role at the current company?
John Hey's current role is CSO, Alzheon, Inc.
What is John Hey's email address?
John Hey's email address is jh****@****hoo.com
What is John Hey's direct phone number?
John Hey's direct phone number is +133968*****
What schools did John Hey attend?
John Hey attended University Of Oklahoma Health Sciences Center, Kansas State University.
What are some of John Hey's interests?
John Hey has interest in Classical Music, Ou Sooner Football, See 1+see Less, Investing, Drug Development, Art, Chess, History, The New York Yankees, Hiking.
What skills is John Hey known for?
John Hey has skills like Drug Discovery, Drug Development, Pharmacology, Clinical Development, Translational Medicine, Biotechnology, Biopharmaceuticals, Toxicology, Pharmacokinetics, Oncology, In Vivo, Scientific Management.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial